Synopsis of recent research by authors named "Taylor L Swan"
- Taylor L Swan's research primarily focuses on hepatitis C virus (HCV) management among people who inject drugs (PWID), emphasizing the high prevalence of HCV in this population and the persistent barriers to treatment.
- Swan's articles highlight the importance of tailored recommendations for HCV care, addressing disparities in treatment access, particularly in high-income and low- to middle-income countries.
- The findings underscore the need for systemic changes in healthcare policies and Medicaid reimbursement criteria to ensure equitable access to effective HCV therapies for PWID and individuals with co-infections, such as HIV.
